Shorter treatment time may ease bladder cancer therapy side effects
NCT ID NCT04701151
Summary
This study is testing if reducing the amount of time a standard bladder cancer treatment (BCG) stays in the bladder can make side effects less severe. It involves 314 patients with high-risk non-muscle invasive bladder cancer across Nordic countries. The goal is to help more patients complete their full treatment course by making it more tolerable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SIDE EFFECT OF DRUG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus University Hospital
Aarhus, Aarhus N, 8200, Denmark
-
Department of Urology, Aalborg University Hospital
Aalborg, 9100, Denmark
-
Department of Urology, Rigshospitalet
Copenhagen, 2100, Denmark
-
Herlev Hospital
Herlev, Denmark
-
Karolinska University Hospital
Stockholm, 141-86, Sweden
-
Landspitali University Hospital
Reykjavik, 101, Iceland
-
Odense University Hospital
Odense, 5000, Denmark
-
PO Sahlgrenska Universitetssjukhuset
Gothenburg, sw 413 45, Sweden
-
Regional Hospital Gødstrup
Herning, 7400, Denmark
-
Zealand University Hospital
Roskilde, 4000, Denmark
-
Örebro University Hospital
Örebro, 701 85, Sweden
Conditions
Explore the condition pages connected to this study.